دورية أكاديمية
أعرض في EDS

Improving the prevention and diagnosis of melanoma on a national scale: A comparative study of performance in the United Kingdom and Australia.

التفاصيل البيبلوغرافية
العنوان: Improving the prevention and diagnosis of melanoma on a national scale: A comparative study of performance in the United Kingdom and Australia.
المؤلفون: Papachristou I; Department of Bio-Engineering, Imperial College London, Kensington, London, SW7 2AZ, UK. yiannis.papachristou123@gmail.com., Bosanquet N; Department of Bio-Engineering, Imperial College London, Kensington, London, SW7 2AZ, UK.
المصدر: Journal of public health policy [J Public Health Policy] 2020 Mar; Vol. 41 (1), pp. 28-38.
نوع المنشور: Comparative Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Palgrave Macmillan Country of Publication: England NLM ID: 8006508 Publication Model: Print Cited Medium: Internet ISSN: 1745-655X (Electronic) Linking ISSN: 01975897 NLM ISO Abbreviation: J Public Health Policy Subsets: MEDLINE
أسماء مطبوعة: Publication: 2005- : Basingstoke, England : Palgrave Macmillan
Original Publication: [Burlington, Vt., Journal of Public Health Policy, inc.]
مواضيع طبية MeSH: Melanoma/*diagnosis , Melanoma/*prevention & control , Skin Neoplasms/*diagnosis , Skin Neoplasms/*prevention & control, Artificial Intelligence ; Australia/epidemiology ; Early Diagnosis ; Humans ; Incidence ; Melanoma/epidemiology ; Public Health ; Skin Neoplasms/epidemiology ; State Medicine ; United Kingdom/epidemiology
مستخلص: We undertook this study in light of an uncontrolled rise of melanoma incidence and mortality rates in the United Kingdom (UK). We aim to assess the effectiveness of prevention and early melanoma diagnosis in the UK's National Health Service (NHS) in comparison to the Australian system that has limited the melanoma rise. We compare the prevention campaigns against skin cancer and the stage at which melanoma is diagnosed. We analyse key drivers of early diagnosis. Overall, Australia has performed better than the UK and provides an example for the UK's NHS for better preventing melanoma and diagnosing it. Technologies under development, such as tele-dermatology and artificial intelligence applications, could aid in making melanoma early diagnosis easier, more cost-efficient, and lessen the burden on health systems. Diagnoses also provide the data to help public health officials target prevention programs.
References: Cancer Research UK. Melanoma skin cancer incidence statistics. 2018. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/melanoma-skin-cancer/incidence#heading-Two . Accessed 15 Dec 2018.
Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality (ACIM) books. ACIM books: melanoma of the skin. Canberra: Australian Institute of Health and Welfare; 2018. http://www.aihw.gov.au/acimbooks . Accessed 18 Dec 2018.
Cancer Research UK. Melanoma skin cancer survival statistics. 2018. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/melanoma-skin-cancer/survival#heading-Three . Accessed 18 Dec 2018.
Elliott T, Whiteman D, Olsen C, Gordon L. Estimated healthcare costs of melanoma in Australia over 3 years post-diagnosis. Appl Health Econ Health Policy. 2017;15(6):805–16. (PMID: 10.1007/s40258-017-0341-y)
Markovic S, Erickson L, Rao R, McWilliams R, Kottschade L, Creagan E, et al. Malignant melanoma in the 21st century, Part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364–80. (PMID: 10.1016/S0025-6196(11)61033-1)
Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130–41. (PMID: 10.1038/s41416-018-0029-6)
International Agency for Research on Cancer. Exposure to artificial UV radiation and skin cancer. Geneva: World Health Organization; 2006.
Lazovich D, Vogel R, Berwick M, Weinstock M, Anderson K, Warshaw E. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomark Prev. 2010;19(6):1557–68. (PMID: 10.1158/1055-9965.EPI-09-1249)
National Institute for Health and Care Excellence (NICE). Melanoma: assessment and management. London: NICE; 2015. https://www.nice.org.uk/guidance/ng14/resources/melanoma-assessment-and-management-pdf-1837271430853 . Accessed 10 Dec 2018.
Australian Cancer Network (ACN) and New Zealand Guidelines Group (NZGG). Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Wellington: Australian Cancer Network Melanoma Guidelines Revision Working Party; 2008.
Menzies S. Technologies for the diagnosis of primary melanoma of the skin. Med J Aust. 2006;185(10):533–4. (PMID: 10.5694/j.1326-5377.2006.tb00685.x)
Plüddemann A, Heneghan C, Thompson M, Wolstenholme J, Price C. Dermoscopy for the diagnosis of melanoma: primary care diagnostic technology update. Br J Gen Pract. 2011;61(587):416–7. (PMID: 10.3399/bjgp11X578142)
Gershenwald J, Scolyer R. Correction to: Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol. 2018;25(S3):993–4. (PMID: 10.1245/s10434-018-6689-x)
Kantor J, Kantor D. Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol. 2009;145(8):873–6. (PMID: 10.1001/archdermatol.2009.137)
Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Sammarco E, Delfino M. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Arch Dermatol. 1998;134(12):1563–70. (PMID: 10.1001/archderm.134.12.1563)
Johr R. Dermoscopy: alternative melanocytic algorithms—the ABCD rule of dermatoscopy, menzies scoring method, and 7-point checklist. Clin Dermatol. 2002;20(3):240–7. (PMID: 10.1016/S0738-081X(02)00236-5)
British Association of Dermatologists—Sun Awareness. Bad.org.uk. 2018. http://www.bad.org.uk/for-the-public/sun-awareness-campaign . Accessed 26 Dec 2018.
Public Health England, Cancer Research UK, NHS England. Pharmacy public health campaign evaluation. Sun safety and skin cancer awareness—July/Aug 2017. London: Cancer Research UK; 2018.
Noticed a change to your skin? Nhs.uk. 2018. https://www.nhs.uk/be-clear-on-cancer/symptoms/skin-cancer . Accessed 19 Dec 2018.
West N. NHS England South West, men urged to “Cover Up, Mate” as skin cancer in men continues to rise. England.nhs.uk. 2018. https://www.england.nhs.uk/south/2016/07/18/coverupmate/ . Accessed 19 Dec 2018.
Campaigns and events. Cancer.org.au. 2017. https://www.cancer.org.au/preventing-cancer/sun-protection/campaigns-and-events/ . Accessed 27 Dec 2018.
Cancer Research UK. Trends in awareness and behaviour relating to UV and sun protection: 2003-2013. London: Cancer Research UK; 2014.
National Cancer Control Indicators. Sunburn and sun protection. 2018. https://ncci.canceraustralia.gov.au/prevention/sun-exposure/sunburn-and-sun-protection . Accessed 28 Dec 2018.
National Cancer Registration and Analysis Service (NCRAS). Routes to diagnosis 2006-2015 2.0b. 2017. London: Public Health England. http://www.ncin.org.uk/publications/routes_to_diagnosis . Accessed 18 Dec 2018.
National Cancer Control Indicators. Distribution of cancer stage. 2018. https://ncci.canceraustralia.gov.au/diagnosis/distribution-cancer-stage/distribution-cancer-stage . Accessed 21 Dec 2018.
National Cancer Registration and Analysis Service (NCRAS). Routes to diagnosis 2006-2016 workbook. London: Public Health England; 2018. http://www.ncin.org.uk/publications/routes_to_diagnosis . Accessed 10 Dec 2018.
Newton-Bishop J, Lorigan P. Identifying melanomas in primary care: can we do better? Br Med J. 2012;345:e4244. (PMID: 10.1136/bmj.e4244)
Cox N, Madan V, Sanders T. The U.K. skin cancer ‘two-week rule’ proforma: assessment of potential modifications to improve referral accuracy. Br J Dermatol. 2008;158(6):1293–8. (PMID: 10.1111/j.1365-2133.2008.08519.x)
Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3(3):159–65. (PMID: 10.1016/S1470-2045(02)00679-4)
Vestergaard M, Macaskill P, Holt P, Menzies S. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol. 2008;159:669–76.
Forsea A, Tschandl P, Zalaudek I, del Marmol V, Soyer H, Argenziano G, et al. The impact of dermoscopy on melanoma detection in the practice of dermatologists in Europe: results of a pan-European survey. J Eur Acad Dermatol Venereol. 2017;31(7):1148–56. (PMID: 10.1111/jdv.14129)
Argenziano G, Puig S, Zalaudek I, Sera F, Corona R, Alsina M, et al. Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol. 2006;24(12):1877–82. (PMID: 10.1200/JCO.2005.05.0864)
Australian Government. Australian Government response to the House of Representatives Standing Committee on health report: skin cancer in Australia: our national cancer. Canberra: Commonwealth of Australia; 2017.
Department of Health. Australia’s future health workforce—dermatology. Canberra: Department of Health Australia; 2017.
Alarcon I, Carrera C, Palou J, Alos L, Malvehy J, Puig S. Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions. Br J Dermatol. 2014;170(4):802–8. (PMID: 10.1111/bjd.12678)
Edwards S, Mavranezouli I, Osei-Assibey G, Marceniuk G, Wakefield V, Karner C. VivaScope ® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation. Health Technol Assess. 2016;20(58):1–260. (PMID: 10.3310/hta20580)
Wilson E, Emery J, Louise Kinmonth A, Toby Prevost A, Morris H, Humphrys E, et al. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model. Value Health. 2013;16(2):356–66. (PMID: 10.1016/j.jval.2012.12.008)
Malvehy J, Hauschild A, Curiel-Lewandrowski C, Mohr P, Hofmann-Wellenhof R, Motley R, et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety. Br J Dermatol. 2014;171(5):1099–107. (PMID: 10.1111/bjd.13121)
British Association of Dermatologists. The role of teledermatology in the delivery of dermatology services. London: British Association of Dermatologists; 2010. http://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=1611 . Accessed 10 Dec 2018.
Elmslie P, Elton H. The implementation of teledermatology in Australia. Woden Town Centre: Department of Health & Ageing Australia; 2011. http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/DD0F66183EDF57C6CA257CD20004A3A1/$File/CHSWTFsub-TeleDerm.pdf . Accessed 10 Dec 2018.
Bataille V, Hargest E, Brown V, Blackwell V, Dawe S, Cooper A, et al. A teledermatology pilot study in hertfordshire. Triage of 2 week wait referrals. In: The 91st annual meeting of the British Association of Dermatologists. London: British Teledermatology Society; 2011. https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2133.2011.10290.x . Accessed 31 Dec 2018.
Tan E, Yung A, Jameson M, Oakley A, Rademaker M. Successful triage of patients referred to a skin lesion clinic using teledermoscopy (IMAGE IT trial). Br J Dermatol. 2009;162(4):803–11. (PMID: 10.1111/j.1365-2133.2010.09673.x)
Snoswell C, Caffery L, Whitty J, Soyer H, Gordon L. Cost-effectiveness of skin cancer referral and consultation using teledermoscopy in Australia. JAMA Dermatol. 2018;154(6):694. (PMID: 10.1001/jamadermatol.2018.0855)
Walters L, Scott R, Mars M. Teledermatology scale-up frameworks: a structured review and critique. BMC Health Serv Res. 2018;18(1):588. (PMID: 10.1186/s12913-018-3418-x)
Finch T, Mair F, May C. Teledermatology in the U.K.: lessons in service innovation. Br J Dermatol. 2007;156(3):521–7. (PMID: 10.1111/j.1365-2133.2006.07608.x)
Rat C, Hild S, Rault Sérandour J, Gaultier A, Quereux G, Dreno B, Nguyen J. Use of smartphones for early detection of melanoma: systematic review. J Med Internet Res. 2018;20(4):e135. (PMID: 10.2196/jmir.9392)
Esteva A, Kuprel B, Novoa R, Ko J, Swetter S, Blau H, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115–8. (PMID: 10.1038/nature21056)
فهرسة مساهمة: Keywords: Early diagnosis; Melanoma; National prevention
تواريخ الأحداث: Date Created: 20190904 Date Completed: 20201103 Latest Revision: 20201210
رمز التحديث: 20221213
DOI: 10.1057/s41271-019-00187-0
PMID: 31477796
قاعدة البيانات: MEDLINE
الوصف
تدمد:1745-655X
DOI:10.1057/s41271-019-00187-0